{"id":2279,"date":"2025-03-19T13:55:59","date_gmt":"2025-03-19T06:55:59","guid":{"rendered":"https:\/\/naviva.com.vn\/?p=2279"},"modified":"2025-10-03T07:46:20","modified_gmt":"2025-10-03T00:46:20","slug":"naviva-group-attends-scientific-seminar-on-influenza-vaccine","status":"publish","type":"post","link":"https:\/\/naviva.com.vn\/en\/naviva-group-attends-scientific-seminar-on-influenza-vaccine","title":{"rendered":"NAVIVA GROUP ATTENDS SCIENTIFIC SEMINAR ON INFLUENZA VACCINE"},"content":{"rendered":"

Seasonal influenza is a serious illness that not only affects health but also places a significant socio-economic burden. Among prevention methods, vaccination is the most effective measure to greatly reduce the risk of infection and severe complications.<\/span><\/p>\n

The seminar \u201cInfluenza Vaccine: The Journey to Protect Communities Against Seasonal Influenza\u201d, organized by Abbott on March 16, 2025, provided important updates on the scientific basis, clinical data, and the latest recommendations regarding the benefits and safety of influenza vaccination\u2014especially for high-risk groups such as the elderly, individuals with underlying conditions, and pregnant women. The event also highlighted Abbott\u2019s 40-year journey of research and development in subunit influenza vaccines, reaffirming its commitment to supporting communities in the fight against influenza.<\/span><\/p>\n

\"\"<\/a><\/span><\/p>\n

On <\/span><\/i>March 16, 2025<\/i><\/b>, several representatives of <\/span><\/i>Naviva Group<\/i><\/b> attended the scientific seminar \u201cInfluenza Vaccine: The Journey to Protect Communities Against Seasonal Influenza\u201d organized by Abbott at the Sheraton Hotel, Ho Chi Minh City.<\/span><\/i><\/span><\/p>\n

With the participation of more than <\/span>500 doctors<\/b> from vaccination centers and obstetrics\u2013pediatrics departments in Ho Chi Minh City, as well as other provinces such as Can Tho, Dong Thap, An Giang, Vinh Long, Tra Vinh, Long An, Binh Duong, Tien Giang, and Dong Nai, the seminar offered valuable scientific insights. It was also an opportunity for Naviva Group to connect, exchange expertise, and update the latest medical knowledge in order to further enhance the quality of services in vaccine distribution.<\/span><\/span><\/p>\n

\"\"<\/a><\/span><\/p>\n

 <\/p>\n

NAVIVA GROUP \u2013 A TRUSTED PARTNER IN MARKETING & DISTRIBUTION OF VACCINES AND BIOLOGICAL PRODUCTS<\/b><\/span><\/h3>\n

NAVIVA GROUP<\/span><\/a> is proud to be a leading and trusted distributor of Abbott\u2019s Influvac Tetra, a quadrivalent influenza vaccine covering four strains (two influenza A strains: H1N1 and H3N2, and two influenza B strains).<\/span><\/span><\/p>\n

\"\"<\/a><\/span><\/p>\n

For more information, please contact:<\/span><\/p>\n